Condition: Pulmonary Hypertension · Chronic Obstructive Pulmonary Disease · Sponsor: Assistance Publique - Hôpitaux de Paris
ERASE PH-COPD is a randomized double-blind study, with 2 parallel groups. Patients with severe pulmonary hypertension due to chronic obstructive pulmonary disease, will be randomly assigned to receive Tadalafil orally or placebo.
This description comes directly from the study's public registry record.
David Pr MONTANI, PU-PH · 01 45 21 78 85 · david.montani@aphp.fr
Always discuss trial participation with your own doctor first.
| Kremlin Bicêtre | Le Kremlin-Bicêtre, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05844462